Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)

NCT07292246 is registered in ClinicalTrials.gov with Vasileios Kalles as lead sponsor.

NCT NCT07292246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07292246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)
Lead sponsor
Vasileios Kalles
Phase
Not applicable
Overall status
Recruiting
Start date
September 9, 2025
Completion date
October 31, 2029
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca 1 gene mutation, brca 2 gene mutation, breast cancer, breast neoplasms, dcis, early breast cancer, germline mutation abnormality, hereditary breast carcinoma